RxDoctor Payments DataLook up a doctor →

Scott Farnham, MD

Urology · Carmel, INNPI 1447264676

Payments from drug & device makers

$30,156in general payments, 2019–2025

Across 278 payments — averaging $108.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$8K
  • Johnson & Johnson$7K
  • Intuitive Surgical$6K
  • Bayer$5K
  • Astellas Pharma US Inc$699
  • Dendreon Pharmaceuticals LLC$434
  • plus $4K from 42 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis10$7,715
Johnson & Johnson35$6,631
Intuitive Surgical5$6,267
Bayer32$4,620
Astellas Pharma US Inc23$699
Dendreon Pharmaceuticals LLC15$434
Pfizer25$416
Sanofi9$301
Sumitomo Pharma America, Inc.11$289
Merck9$282
Accord Healthcare, Inc.9$216
Rochester Medical Corporation4$191
Sun Pharmaceutical Industries Inc.4$167
Progenics Pharmaceuticals, Inc.4$164
AstraZeneca7$149
AbbVie8$130
Janssen Scientific Affairs, LLC1$115
Myriad Genetic Laboratories, Inc.4$91
Urogen Pharma, Inc.4$85
Endo USA, Inc.4$85
Clovis Oncology, Inc.2$82
Amgen6$81
Telix Pharmaceuticals2$77
Tolmar, Inc.3$71
Myovant Sciences Inc.2$63
Medtronic(2 entities)3$54
C. R. Bard, Inc. & Subsidiaries1$46
Foundation Medicine, Inc.3$45
Antares Pharma, Inc.3$43
Hollister Incorporated1$43
Civco Medical Instruments1$41
Calyxo, Inc.2$41
Endo Pharmaceuticals Inc.3$41
Tolmar Pharmaceuticals, Inc.2$38
Aytu Biopharma, Inc.2$36
Immunitybio, Inc.2$34
Verity Pharmaceuticals Inc.2$33
Boston Scientific2$32
Ferring Pharmaceuticals Inc.2$31
Laborie Medical Technologies Corp.2$29
Dentsply IH AB1$25
Inspire Medical Systems, Inc.1$25
Coloplast1$23
Davol Inc.1$21
Tempus AI, Inc1$17
Travere Therapeutics, Inc.2$17
EDAP Technomed Inc1$12
Clarus Therapeutics Inc.1$9

How this compares

$30,156 in reported general payments places this provider in the 80th percentile of 272 urology providers in Indiana.

See all urology providers in Indiana →

Medicare billing

Part B allowed, 2024
$972,477
Medicare patients
670
Services billed
15,942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Carmel

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →